{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:30:35Z","timestamp":1781019035500,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T00:00:00Z","timestamp":1406246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00702-014-1278-z","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T11:59:57Z","timestamp":1406203197000},"page":"427-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Blepharospasm: long-term treatment with either Botox\u00ae, Xeomin\u00ae or Dysport\u00ae"],"prefix":"10.1007","volume":"122","author":[{"given":"Katja","family":"Kollewe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Pickenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,25]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"crossref","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR (2014) Long-term efficacy and safety of botulinum toxin a injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol 42(3):254\u2013261","DOI":"10.1111\/ceo.12165"},{"key":"1278_CR2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mds.25579","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A (2013) Dystonia rating scales: critique and recommendations. Mov Disord 28:874\u2013883","journal-title":"Mov Disord"},{"key":"1278_CR3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12640-009-9023-3","volume":"15","author":"AR Bentivoglio","year":"2009","unstructured":"Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo FS, Albanese A (2009) Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotox Res 15:224\u2013231","journal-title":"Neurotox Res"},{"key":"1278_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/112067210301300401","volume":"13","author":"P Calace","year":"2003","unstructured":"Calace P, Cortese G, Piscopo R, Della VG, Gagliardi V, Magli A, De BT (2003) Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol 13:331\u2013336","journal-title":"Eur J Ophthalmol"},{"key":"1278_CR5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/eye.2009.192","volume":"24","author":"S Cillino","year":"2010","unstructured":"Cillino S, Raimondi G, Guepratte N, Damiani S, Cillino M, Di PF, Casuccio A (2010) Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye (Lond) 24:600\u2013607","journal-title":"Eye (Lond)"},{"key":"1278_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajo.2013.02.001","volume":"156","author":"CN Czyz","year":"2013","unstructured":"Czyz CN, Burns JA, Petrie TP, Watkins JR, Cahill KV, Foster JA (2013) Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Am J Ophthalmol 156:173\u2013177","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 2","key":"1278_CR32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2009.02877.x","volume":"16","author":"D Dressler","year":"2009","unstructured":"Dressler D (2009) Routine use of Xeomin in patients pre-treated with Botox: long term results. Eur J Neurol 16(Suppl 2):2\u20135","journal-title":"Eur J Neurol"},{"key":"1278_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-1331.2011.03559.x","volume":"19","author":"D Dressler","year":"2012","unstructured":"Dressler D (2012) Five-year experience with incobotulinumtoxinA (Xeomin((R))): the first botulinum toxin drug free of complexing proteins. Eur J Neurol 19:385\u2013389","journal-title":"Eur J Neurol"},{"key":"1278_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","volume":"49","author":"D Dressler","year":"2003","unstructured":"Dressler D, Benecke R (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49:34\u201338","journal-title":"Eur Neurol"},{"key":"1278_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000081463","volume":"52","author":"D Dressler","year":"2004","unstructured":"Dressler D, Bigalke H (2004) Antibody-induced failure of botulinum toxin type B therapy in de novo patients. Eur Neurol 52:132\u2013135","journal-title":"Eur Neurol"},{"key":"1278_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00702-011-0719-1","volume":"119","author":"D Dressler","year":"2012","unstructured":"Dressler D, Mander G, Fink K (2012) Measuring the potency labelling of onabotulinumtoxinA (Botox(R)) and incobotulinumtoxinA (Xeomin (R)) in an LD50 assay. J Neural Transm 119:13\u201315","journal-title":"J Neural Transm"},{"key":"1278_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00702-013-1076-z","volume":"121","author":"D Dressler","year":"2014","unstructured":"Dressler D, Tacik P, Adib SF (2014a) Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(R)) and incobotulinumtoxinA (Xeomin (R)). J Neural Transm 121:29\u201331","journal-title":"J Neural Transm"},{"key":"1278_CR10","doi-asserted-by":"crossref","unstructured":"Dressler D, Tacik P, Adib SF (2014b) Botulinum toxin therapy for cervical dystonia: duration of therapeutic effects. J Neural Transm. doi: 10.1007\/s00702-014-1253-8","DOI":"10.1007\/s00702-014-1253-8"},{"key":"1278_CR13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","volume":"95","author":"JJ Dutton","year":"1988","unstructured":"Dutton JJ, Buckley EG (1988) Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95:1529\u20131534","journal-title":"Ophthalmology"},{"key":"1278_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","volume":"52","author":"JJ Dutton","year":"2007","unstructured":"Dutton JJ, Fowler AM (2007) Botulinum toxin in ophthalmology. Surv Ophthalmol 52:13\u201331","journal-title":"Surv Ophthalmol"},{"key":"1278_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.toxicon.2009.03.010","volume":"54","author":"J Frevert","year":"2009","unstructured":"Frevert J (2009) Xeomin is free from complexing proteins. Toxicon 54:697\u2013701","journal-title":"Toxicon"},{"key":"1278_CR16","first-page":"OP595","volume":"81","author":"BR Frueh","year":"1976","unstructured":"Frueh BR, Callahan A, Dortzbach RK, Wilkins RB, Beale HL, Reitman HS, Watson FR (1976) The effects of differential section of the VIITH nerve on patients with intractable blepharospasm. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 81:OP595\u2013OP602","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"1278_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nrl.2012.03.009","volume":"28","author":"PC Gil","year":"2013","unstructured":"Gil PC, Rodriguez Sanz MF, Berrocal IN, Castrillo SA, Gutierrez RR, Zamora Garcia MI, Mendoza RA, Duarte Garcia-Luis J (2013) Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin. Neurologia 28:131\u2013136","journal-title":"Neurologia"},{"key":"1278_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S0317167100010817","volume":"37","author":"HS Gill","year":"2010","unstructured":"Gill HS, Kraft SP (2010) Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm. Can J Neurol Sci 37:631\u2013636","journal-title":"Can J Neurol Sci"},{"key":"1278_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N, Marsden CD (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51:767\u2013772","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1278_CR20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O (2002) Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17:1288\u20131293","journal-title":"Mov Disord"},{"key":"1278_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","volume":"13","author":"J Jankovic","year":"1983","unstructured":"Jankovic J, Ford J (1983) Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 13:402\u2013411","journal-title":"Ann Neurol"},{"key":"1278_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","volume":"115","author":"C Kenney","year":"2008","unstructured":"Kenney C, Jankovic J (2008) Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 115:585\u2013591","journal-title":"J Neural Transm"},{"key":"1278_CR23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00702-010-0409-4","volume":"117","author":"K Kollewe","year":"2010","unstructured":"Kollewe K, Mohammadi B, Dengler R, Dressler D (2010) Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. J Neural Transm 117:759\u2013763","journal-title":"J Neural Transm"},{"key":"1278_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/174313209X405137","volume":"31","author":"B Mohammadi","year":"2009","unstructured":"Mohammadi B, Buhr N, Bigalke H, Krampfl K, Dengler R, Kollewe K (2009) A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res 31:463\u2013466","journal-title":"Neurol Res"},{"key":"1278_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/016164109X12478302362734","volume":"32","author":"B Mohammadi","year":"2010","unstructured":"Mohammadi B, Balouch SA, Dengler R, Kollewe K (2010) Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients. Neurol Res 32:309\u2013313","journal-title":"Neurol Res"},{"key":"1278_CR26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","volume":"3","author":"JG Nutt","year":"1988","unstructured":"Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ III (1988) Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 3:188\u2013194","journal-title":"Mov Disord"},{"key":"1278_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000008121","volume":"43","author":"JD Rollnik","year":"2000","unstructured":"Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H (2000) Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Eur Neurol 43:9\u201312","journal-title":"Eur Neurol"},{"key":"1278_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0004-282X2005000200006","volume":"63","author":"L Silveira-Moriyama","year":"2005","unstructured":"Silveira-Moriyama L, Goncalves LR, Chien HF, Barbosa ER (2005) Botulinum toxin a in the treatment of blepharospasm: a 10-year experience. Arq Neuropsiquiatr 63:221\u2013224","journal-title":"Arq Neuropsiquiatr"},{"key":"1278_CR29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00702-013-0998-9","volume":"120","author":"DD Truong","year":"2013","unstructured":"Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH (2013) Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin (R)) injections in blepharospasm. J Neural Transm 120:1345\u20131353","journal-title":"J Neural Transm"},{"key":"1278_CR30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00115-008-2486-2","volume":"79","author":"T Vogt","year":"2008","unstructured":"Vogt T, Lussi F, Paul A, Urban P (2008) Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A. Nervenarzt 79:912\u2013917","journal-title":"Nervenarzt"},{"key":"1278_CR31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-010-0546-9","volume":"118","author":"B Wabbels","year":"2011","unstructured":"Wabbels B, Jost WH, Roggenkamper P (2011) Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. J Neural Transm 118:925\u2013943","journal-title":"J Neural Transm"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1278-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-014-1278-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1278-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:26:44Z","timestamp":1565656004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-014-1278-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,25]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1278-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,25]]}}}